Rating History for Y-mAbs Therapeutics (YMAB) by H.C. Wainwright

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/6/2025 Robert Burns Downgrade Neutral
(Buy)
N/A
(N/A)
8.52
(8.61)
1.06% Details